Malignant peripheral nerve sheath tumor (MPNST) and MPNST-like entities are defined by a specific DNA methylation profile in pediatric and juvenile population. [PDF]
Patrizi S +21 more
europepmc +1 more source
GLI1/2-altered mesenchymal tumors: a study of 8 cases expanding the clinicopathological and molecular spectrum including an upstream PTCH1-inactivating mutation. [PDF]
Hiemcke-Jiwa LS +11 more
europepmc +1 more source
Utility of [<sup>99m</sup>Tc]Tc-tilmanocept, an immunosuppressive macrophage functional imaging agent in melanoma patients receiving checkpoint inhibitor treatment: a feasibility study. [PDF]
Boughdad S +8 more
europepmc +1 more source
New models for MPNST: establishment and comprehensive characterization of two tumor cell lines. [PDF]
Ortega-Bertran S +10 more
europepmc +1 more source
Assessment of the clinical and morphological characteristics of visceral melanoma metastases and primary extracutaneous melanomas. [PDF]
Natarâş BR +9 more
europepmc +1 more source
Dramatic Responses to High-Dose Ipilimumab Plus Temozolomide After Progression on Standard- or Low-Dose Ipilimumab in Advanced Melanoma. [PDF]
Williamson J +18 more
europepmc +1 more source
Depigmentation of Melanin-containing Tissues Using Hypochlorous Acid to Enhance Hematoxylin-eosin and Immunohistochemical Staining. [PDF]
Wang L, Wang G.
europepmc +1 more source
A Phase I, First-in-Human, Dose-Escalation, Expansion Trial of Cytokine-Encoding Synthetic mRNA Mixture Alone or with Cemiplimab in Advanced Solid Tumors. [PDF]
Bechter O +27 more
europepmc +1 more source

